![]() |
||||
|
Disclaimer:
This book was created after the 1998 Family Conference. The articles are important to all of those involved with RTS. This is online without permission from Dr. Rubinstein and the Cincinnatti Rubinstein-Taybi organization. They would prefer that you call Dr. Rubinstein at 1-800-344-2462 ext. 4621 and request a copy of the book. I would encourage everyone, especially those with a child who has RTS to call the above number and request a copy of this book. I have been reassured by Mark Shannon that this book will be sent to anyone who requests it, regardless of country.
|
||||
|
Chromosome 16 Microdeletions in Rubinstein-Taybi |
||||
|
Ruthann I Blough1, Fred Petrij2, Johannes G. Dauwerse2, Lester Weiss3, Paula Czarneck3, Jack H. Rubinstein1, Howard M. Saal1 1The Children’s Hospital Medical Center (CHMC), Cincinnati OH, 2Department of Human Genetics, Leiden University, The Netherlands, 3Henry Ford Hospital, Detroit, MI |
|
The Rubinstein-Taybi syndrome (RTS) is a rare condition characterized by broad thumbs and broad big toes, facial dysmorphism, and mental retardation. FISH using probes specific to chromosomes 16p13.3 identified microdeletions in 20-25% of initially reported cases. Later studies, however, have suggested a somewhat lower rate of microdeletions. The disrupted gene has been identified as coding for the CREB-binding protein (CBP). In the majority of cases studied by FISH the prove used was specific to the 3’ region of the CBP gene. In cases studied with additional probes, individuals with deletions detected by FISH appear to be deleted for the 3’ ends as well as the entire CBP gene. We have performed FISH on a series of 70 patients with an established diagnosis of RTS, using a panel of 5 cosmids which span the CBP gene. The initial 43 samples were collected during the 1993 International Family Conference on Rubinstein-Taybi Syndrome in Cincinnati, OH. Each of these individuals was examined by the same team of physicians and had a clinically confirmed diagnosis of RTS. An additional 27 samples were collected after the conference from a wide variety of referring institutions. Of 70 individuals examined, 64 had no detectable deletion. This represents a lower than expected rate of deletion by FISH based on the widely quoted rate of 20-25%. Six patients demonstrated complete or partial deletion of the CBP gene (Figure 1, below.) The finding of two paretial, 5’ deletions and an interstitial deletion of the 3’ region of the CBP gene among these individuals adds to the known spectrum of mutations of this gene in RTS. These studies demonstrate the need for evaluation of the entire CBP gene region for deletions in RTS patients rather than only the 3’ region, since 3 of 6 deletions would have missed if only the 3’ FISH probe were used. Further, this study supports more recent reports that the true rate of microdeletion across the CBP gene detectable by FISH is ~10% of confirmed cases of RTS, FISH is a poor diagnostic test. A deletion-positive study can be confirmatory, but a deletion-negative study cannot rule out a diagnosis of RTS. Different approaches to the clinical laboratory diagnosis of RTS continue to be explored at CHMC Cincinnati. |
|
|
|
|
Funding: |
|
This document was added to the Rubinstein-Taybi web site in November 2000. |
||||
|
If any of the information found on this website does not adhere to copyright laws it is unintentional, please contact dwardlow@uswest.net and it will be removed from the site. |
||||
|
http://www.rubinstein-taybi.org
|
||||